Xu Yan, Li Xue-jun
Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
Yao Xue Xue Bao. 2009 Mar;44(3):226-30.
Drugs acting on individual molecular targets usually exert unsatisfying therapeutic effects or have severe toxicity when used in diseases of complicated causes such as tumor, diabetes and inflammation. Multitarget therapeutics which regulates multiple nodes of the disease network simultaneously shows synergistic effect, is unlikely to induce resistance and provides optimal clinical use. This review summarized the characteristics, classification, development strategies and screening models, current multi-target therapeutic drugs used in clinic and also explored the potential of TCM in multi-target therapeutics.
作用于单个分子靶点的药物在用于治疗肿瘤、糖尿病和炎症等病因复杂的疾病时,通常疗效不尽人意或具有严重毒性。同时调节疾病网络多个节点的多靶点疗法具有协同效应,不太可能诱导耐药性,并能提供最佳临床应用效果。本文综述了多靶点疗法的特点、分类、研发策略和筛选模型,介绍了目前临床使用的多靶点治疗药物,并探讨了中药在多靶点治疗中的潜力。